A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Condition:   Treatment of Malignancy Associated Weight Loss or Anorexia in Patients With NSCLC Interventions:   Drug: Anamorelin Hydrochloride;   Drug: Placebo Oral Tablet Sponsor:   Helsinn Healthcare SA Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials